DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 39 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactResults

Vaxtex Cotfab Limited — Outcome of Board Meeting

NSE 3 hrs ago·10 Aug 2026, 12:31 pm

Vaxtex Cotfab

Vaxtex Cotfab Limited has informed the stock exchange that its board has approved the financial results for the period ending June 30, 2026. This filing is a routine corporate governance requirement and signals that the company has finalized its accounts for the specified quarter.

For investors, this update provides the latest data on Vaxtex's operational performance and financial health. While the specific figures are not yet disclosed, the announcement confirms that the company is on track to report its earnings, which is essential for tracking its profitability and growth trajectory.

Investors should watch for the detailed financial statements to be released shortly. Key areas of focus will include revenue growth, operating margins, and any commentary from management regarding future business prospects.